VCEL logo

VCELVericel Corp

$36.30
$0.61
(1.71%)
Today
Closed $36.30
$0.00
(0.00%)
After Hours
Updated: 04:10 PM EDT
Reported EarningsMay 7
Mkt Cap$1.82B
Vol558,274.00
News
all
press releases
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More...
Yahoo! Finance: News
News Placeholder
More News
News Placeholder
Vericel (VCEL) Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
News Placeholder
Vericel Corporation (VCEL) Reports Q1 Loss, Beats Revenue Estimates
Vericel (VCEL) delivered earnings and revenue surprises of +17.24% and +7.25%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Wall Street Analysts Think Vericel (VCEL) Could Surge 53.42%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 53.4% in Vericel (VCEL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks
News Placeholder
Conestoga Capital Advisors LLC Acquires 79,278 Shares of Vericel Corporation $VCEL
Conestoga Capital Advisors LLC grew its holdings in Vericel Corporation (NASDAQ:VCEL - Free Report) by 3.6% in the fourth quarter, according to the company in its most recent 13F filing with the...
MarketBeat
News Placeholder
Vericel Annual Meeting: Shareholders Elect Seven Directors, Approve Say-on-Pay and PwC Auditor
Vericel (NASDAQ:VCEL) held its 2026 annual meeting of shareholders on April 29 in a virtual format, with Chairman Dr. Robert Zerbe presiding. Zerbe said the meeting was conducted pursuant to Michigan law, the company's bylaws, and the notice distributed to shareholders. Sean Flynn, Vericel's corpora...
MarketBeat
News Placeholder
Vericel Corporation (NASDAQ:VCEL) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Vericel Corporation (NASDAQ:VCEL - Get Free Report) have been given an average rating of "Moderate Buy" by the eight analysts that are presently covering the stock, MarketBeat.com reports...
MarketBeat
News Placeholder
Vericel (NASDAQ:VCEL) Shares Down 7.1% - Time to Sell?
Vericel (NASDAQ:VCEL) Trading Down 7.1% - What's Next...
MarketBeat
News Placeholder
Jonathan Mark Hopper Sells 3,472 Shares of Vericel (NASDAQ:VCEL) Stock
Vericel Corporation (NASDAQ:VCEL - Get Free Report) insider Jonathan Mark Hopper sold 3,472 shares of the stock in a transaction that occurred on Thursday, April 2nd. The stock was sold at an average...
MarketBeat
News Placeholder
Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines
Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines PR Newswire VANCOUVER, BC, April 6, 2026 Issued on behalf...
PR Newswire
<
1
2
...
>

Advertisement|Remove ads.